Adjuvant Radiochemotherapy with a 23-Month Overall Survival Time in a Patient after a Surgery due to Splenic Hemangiosarcoma Rupture: A Case Report with the Literature Review
المؤلفون المشاركون
Cisek, Paweł
Grzybowska-Szatkowska, Ludmiła
Bilski, M.
Surdyka, D.
Paśnik, I.
Bilska, M.
Korona, P.
Szumiło, J.
المصدر
Case Reports in Oncological Medicine
العدد
المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-5، 5ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2018-02-11
دولة النشر
مصر
عدد الصفحات
5
التخصصات الرئيسية
الملخص EN
Spleen sarcoma is one of the most rare soft tissue malignancies.
The annual incidence is 0.14–0.25/1,000,000 and the average age of diagnosis is 50 to 73 years.
The incidence of this cancer has been increasing.
Treatment of choice is surgical splenectomy, which rarely gives good results due to the aggressive course of the disease as well as the high potential for metastasis.
Overall survival in primary spleen sarcomas as described by various authors is between 4 and 14 months.
80% of patients after spleen rupture do not survive 6 months.
We report the case of a 42-year-old male diagnosed with spleen angiosarcoma.
The patient underwent surgery in an emergency mode because of rapid rupture of the organ.
Due to positive surgical margins, he underwent adjuvant radiochemotherapy followed by chemotherapy.
Overall survival time was relatively long (23 months).
The international guidelines provide information based on limited data.
The role of postoperative radiotherapy in angiosarcomas remains controversial.
Postoperative radiotherapy may increase local disease control, especially after nonradical operation, but this does not translate into improvement in overall survival time of these patients.
The case shows that adjuvant radiotherapy as part of cancer treatment strategy may prolong the overall survival.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Bilski, M.& Surdyka, D.& Paśnik, I.& Bilska, M.& Cisek, Paweł& Korona, P.…[et al.]. 2018. Adjuvant Radiochemotherapy with a 23-Month Overall Survival Time in a Patient after a Surgery due to Splenic Hemangiosarcoma Rupture: A Case Report with the Literature Review. Case Reports in Oncological Medicine،Vol. 2018, no. 2018, pp.1-5.
https://search.emarefa.net/detail/BIM-1146632
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Bilski, M.…[et al.]. Adjuvant Radiochemotherapy with a 23-Month Overall Survival Time in a Patient after a Surgery due to Splenic Hemangiosarcoma Rupture: A Case Report with the Literature Review. Case Reports in Oncological Medicine No. 2018 (2018), pp.1-5.
https://search.emarefa.net/detail/BIM-1146632
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Bilski, M.& Surdyka, D.& Paśnik, I.& Bilska, M.& Cisek, Paweł& Korona, P.…[et al.]. Adjuvant Radiochemotherapy with a 23-Month Overall Survival Time in a Patient after a Surgery due to Splenic Hemangiosarcoma Rupture: A Case Report with the Literature Review. Case Reports in Oncological Medicine. 2018. Vol. 2018, no. 2018, pp.1-5.
https://search.emarefa.net/detail/BIM-1146632
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1146632
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر